CLASSIC II
Showing 1 - 25 of >10,000
Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)
Not yet recruiting
- Kaposi Sarcoma
- +2 more
- Pembrolizumab + Lenvatinib
- (no location specified)
Apr 27, 2023
Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Concurrent penpulimab and AVD
- Sequential penpulimab and AVD
- (no location specified)
Jul 10, 2023
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
Primary Teeth Trial in Isparta (Dyract XP (Dentsply De Trey), Kerr Herculite Classic (Kerr Corporation),R&D Series NOVA(Kuraray
Completed
- Primary Teeth
- Dyract XP (Dentsply De Trey), Kerr Herculite Classic (Kerr Corporation),R&D Series NOVA(Kuraray Medical Inc) Clearfil TM SE Bond (Kuraray Medical),Hydrocal LC (Medicept Dental)
-
Isparta, TurkeySuleyman Demirel University Faculty of Dentistry Pediatric Denti
Jul 16, 2022
Emotional Proactive Processing in Bipolar Disorder
Active, not recruiting
- Bipolar Disorder
- +2 more
- Emotional Stroop Task
-
La Tronche, Isère, FranceCHU Grenoble Alpes
May 17, 2022
Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United
Active, not recruiting
- Ann Arbor Stage IB Hodgkin Lymphoma
- +10 more
- Brentuximab Vedotin
- Nivolumab
-
Palo Alto, California
- +8 more
Jul 20, 2022
Multimorbidity Trial in Boston (Vital Moto Mod, Welch Allyn Connex Spot Vital Signs Monitor, Capnostream 20 Portable Bedside
Completed
- Multimorbidity
- Vital Moto Mod
- +4 more
-
Boston, MassachusettsPartners Connected Health
Aug 29, 2020
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent
Not yet recruiting
- Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
- +21 more
- Biopsy
- +8 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 7, 2023
Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +13 more
- Cyclophosphamide
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 18, 2022
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United
Active, not recruiting
- AIDS-Related Hodgkin Lymphoma
- +11 more
- Brentuximab Vedotin
- +4 more
-
La Jolla, California
- +27 more
Jul 27, 2022
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
- Brentuximab vedotin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 20, 2023
Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)
Recruiting
- Safety Issues
- Efficacy, Self
- low dose nivolumab in combination with AVD
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr Jose Eleuterio Gonzalez
Mar 6, 2023
Investigate Contact Sensitization Using Classic and Machine
Recruiting
- Allergic Contact Dermatitis
- patch test for diagnosing allergic contact dermatitis
-
Athens, Attica, GreeceGeorgia Gogkla
Aug 7, 2023
Shock, Septic Trial in Maribor (Simultaneous administration of vasopressors, Successive administration of vasopressors)
Recruiting
- Shock, Septic
- Simultaneous administration of vasopressors
- Successive administration of vasopressors
-
Maribor, SloveniaMedical intensive care unit UMC Maribor
Dec 2, 2023
Kaposi Sarcoma, Progression, Disease Trial in Paris (Pembrolizumab)
Unknown status
- Kaposi Sarcoma
- Progression, Disease
-
Paris, FranceSaint-Louis Hospital
Oct 18, 2019
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Houston (Bortezomib, Carboplatin, Etoposide)
Completed
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Bortezomib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 9, 2020
Hodgkin Lymphoma, Adult Trial in Beijing (SHR-1210)
Completed
- Hodgkin Lymphoma, Adult
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Oct 29, 2021
Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)
Recruiting
- Relapsed Multiple Myeloma
- Belantamab mafodotin
- +2 more
-
Badalona, Spain
- +14 more
Sep 5, 2022
Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, Lugano Classification Stage IV Hodgkin
Acute Coronary Syndrome Trial in Madrid (Multicomponent Psychological Program (MPP))
Completed
- Acute Coronary Syndrome
- Multicomponent Psychological Program (MPP)
-
Madrid, SpainHospital Universitario 12 de Octubre
Mar 17, 2022
Facial Acne Vulgaris Trial in Assiut (retinyl palmitate, Tretinoin)
Completed
- Facial Acne Vulgaris
- retinyl palmitate
- Tretinoin
-
Assiut, EgyptAssiut University Hospital
Nov 10, 2022
Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))
Recruiting
- Hepatocellular Carcinoma
- Fruquintinib
- +2 more
-
Hangzhou, Zhejiang, ChinaGuoliang Shao
Aug 1, 2023